Fig. 13
From: Cell membrane-camouflaged inorganic nanoparticles for cancer therapy
a Platelet membrane–coated siRNA-loaded MOFs (P-MOF-siRNA) for gene silencing. b Growth kinetics of SK-BR-3 tumors implanted subcutaneously into nu/nu mice and treated intravenously with P-MOF-siRNA or R-MOF-siRNA every 3 days for a total of four administrations (n = 5; mean ± SEM). c Survival of the mice over time (n = 5). d Body weight of the mice in (a) over time (n = 5; mean ± SD). Reprinted with permission from Refs [104]